论文部分内容阅读
Aim YL-0919 is permitted by SFDA for clinical trial recently as a new drug for depression. Whether YL-0919 is a fast-onset antidepressant and the possible mechanism related to roTOR pathway will be investigated. Methods Chronic unpredictable stress rat mo